Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1612 1617 1621 1627 1629
This examiner grants 52% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19189086 | RISANKIZUMAB COMPOSITIONS | Non-Final OA | ABBVIE INC. |
| 18036825 | METHODS AND COMPOSITIONS FOR CANCER THERAPY | Non-Final OA | OHIO STATE INNOVATION FOUNDATION |
| 18011399 | REDOX-RESPONSIVE NANOPARTICLE COMPOSITIONS FOR OCULAR DELIVERY OF THERAPEUTICS | Final Rejection | OHIO STATE INNOVATION FOUNDATION |
| 17975485 | COMPOSITIONS, ARTICLES, DEVICES, AND METHODS RELATED TO DROPLETS COMPRISING A CLOAKING FLUID | Non-Final OA | Massachusetts Institute of Technology |
| 18734675 | COSMETIC COMPOSITION INCLUDING A SILOXANE-TREATED COLORANT | Non-Final OA | L'OREAL |
| 18713218 | COSMETIC WATER-IN-OIL EMULSION COMPRISING A SPECIFIC WATER-SOLUBLE UV SCREENING AGENT, A BASE, A VOLATILE OIL, A HYDROPHOBIC FILM-FORMING POLYMER, A POLYOXYALKYLENATED LINEAR POLYDIMETHYLMETHYLSILOXANE AND A VITAMIN B3 | Non-Final OA | L'OREAL |
| 18258777 | COMPOSITION FOR CARING FOR THE KERATIN MATERIALS | Non-Final OA | L'OREAL |
| 18692074 | MULTIPARTICULATE DOSAGE FORMS COMPRISING DEUTETRABENAZINE | Non-Final OA | AUSPEX PHARMACEUTICALS, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy